Baxter Healthcare Corporation recalled 14,400 units of its Continu-Flo solution set on August 8, 2025. The recall follows customer reports of tubing separation that pose serious risks. Healthcare providers and patients must stop using the device immediately.
Baxter Healthcare Corporation is issuing an Urgent Medical Device Recall for one lot of Continu-Flo solution sets listed below due to customer reports of tubing separation.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Baxter Healthcare Corporation or your healthcare provider for instructions. Notification method: Letter
The Continu-Flo solution set features two Clearlink Luer activated valves and a backcheck valve. It has a length of 112 inches (2.8 m) and is identified by product code REF 2C8519.
The tubing separation can lead to serious complications during intravascular administration. This recall has been classified as Class II, indicating a potential risk of injury.
Baxter received multiple reports of tubing separation, but specific incident counts have not been disclosed. No injuries or deaths have been reported at this time.
Patients and healthcare providers should stop using the device immediately. Contact Baxter Healthcare or your healthcare provider for guidance on the recall.
For further information, call Baxter Healthcare Corporation at 1-800-XXX-XXXX or visit their website.
Glenmark Pharmaceuticals Inc. recalled 13,824 tubes of Azelaic Acid Gel on September 17, 2025. The recall stems from market complaints regarding a gritty texture. Consumers should stop using the product immediately and contact their healthcare provider.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.